Jade Biosciences, Inc. Common Stock
JBIO • NASDAQ
Jade Biosciences, Inc. Common Stock is a pharmaceutical preparations company trading on NASDAQ, led by CEO Tom Frohlich, with a market cap of $899.0M.
Market Cap$899.0M
CEOTom Frohlich
CountryUnited States of America
PHARMACEUTICAL PREPARATIONS
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
JBI
Jade Biosciences, Inc. Common Stock FAQ
Common questions about Jade Biosciences, Inc. Common Stock
Jade Biosciences, Inc. Common Stock is scheduled to report earnings for Q1 2026 on May 13, 2026.